MedPath

Effects of alpha lipoic acid supplementation on serum level of visfatin, markers of oxidative stress, inflammation and insulin resistance in patients with chronic renal failure undergoing hemodialysis.

Not Applicable
Conditions
chronic renal failure.
End-stage renal disease
Registration Number
IRCT138806301197N2
Lead Sponsor
utritional Research Center Tabriz University Of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

obtaining informed consent, being on hemodialysis for more than 6 months, receiving 3 times hemodialysis each week
Exclusion criteria: hepatitis and other infections less than 20 years, receiving any NSAID and SAID, alpha lipoic acid supplement, vitamin C, vitamin E, valporic acid in the month prior to the study, presence of gastrointestinal disorders, being candidate for kidney transplantation, pregnancy or lactation, smoking, possibility of any side effect for consumption of the supplement

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath